Table 3.

Stratified Analysis for RSV Hospitalization

Subgroup	RR all Antibody Prophyaxis	# of Studies	# in Treatment Groups
Premature <35 weeks GA[11,12,15]	0.29 (0.16, 0.54)	3	624
Chronic Lung Disease (CLD)[11,12,15]	0.55 (0.38, 0.80)	3	696
Congenital Heart Disease (CHD)[11,12,16]	0.56 (0.40, 0.79)	3	865